OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
17
Results
Show all
Save search
Copy query
Show results for
Unknown
(17)
Release Date
2022
(4)
2021
(4)
2024
(3)
2025
(2)
2023
(1)
2020
(1)
2016
(1)
2009
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial.
Not available
S-EPMC9126560
|
biostudies-literature
Cite
Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19.
Not available
S-EPMC7745180
|
biostudies-literature
Cite
Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-bind, randomised, placebo-controlled, phase 3 trial.
Not available
S-EPMC8523116
|
biostudies-literature
Cite
Genome-wide association study identifies eight loci associated with blood pressure.
Not available
S-EPMC2891673
|
biostudies-literature
Cite
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition).
Not available
S-EPMC4835977
|
biostudies-literature
Cite
Global Retinoblastoma Presentation and Analysis by National Income Level.
Not available
S-EPMC7047856
|
biostudies-literature
Cite
The Global Retinoblastoma Outcome Study: a prospective, cluster-based analysis of 4064 patients from 149 countries.
Not available
S-EPMC9397647
|
biostudies-literature
Cite
Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023.
Not available
S-EPMC12535838
|
biostudies-literature
Cite
Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023.
Not available
S-EPMC12535840
|
biostudies-literature
Cite
Immunomodulators for immunocompromised patients hospitalized for COVID-19: a meta-analysis of randomized controlled trials.
Not available
S-EPMC10867612
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets